在USTR宣布将对挂靠美国港口的中国建造、中国船东所有或中国经营人运营的船舶征收费用后，由法律与商业专家组成的BIMCO小组委员会自6月初起便着手起草该条款，并将其作为优先事项处理。

BEIJING, Aug. 7 (Xinhua) -- The U.S. modified tariffs with dozens of its trading partners are set to take effect on Thursday, amid widespread concern across the globe that the new rates of levies, ...

China opposes the United States' act of politicizing and weaponizing tech and trade issues, foreign ministry spokesperson Guo ...

China opposes the United States' act of politicizing and weaponizing tech and trade issues, foreign ministry spokesperson Guo Jiakun said on August 7. Guo's remarks came after the U.S. Justice ...

BARCELONA, Spain, Aug. 3 (Xinhua) -- The European Union (EU) has little to gain from its new trade deal with the United States, with Germany likely to be the bloc's biggest loser, Sergi Basco, ...

In response to Trump's new threat, India's Ministry of External Affairs said in a statement that "the targeting of India is ...

为解决非洲地区乳腺癌死亡率高但缺乏激素治疗疗效数据的问题，研究人员在肯雅塔国立医院开展了一项回顾性队列研究，比较他莫昔芬与芳香化酶抑制剂 (AIs)对激素受体阳性 (ER+/PR+)乳腺癌患者的疗效。结果显示AIs组在疾病进展率 (24% vs 29.7%)、完全缓解率 (24% vs 13.5%)和中位生存期 (49 vs ...

SEC Chairman Launches 'Project Crypto' in Landmark Regulatory Pivot as Hong Kong's Stablecoin Law Takes Effect ...

Many American companies recognize that being rooted in China is essential to understanding market trends and participating in innovation. As Sean Stein, President of the U.S.-China Business Council (U ...

本研究针对抗癌药物首次人体试验 (FIH)在日本与美国的实施差异展开分析，通过检索2007-2017年ClinicalTrials.gov数据，揭示两国在试验规模、赞助模式及跨国合作方面的显著差异，并首次证实日本FIH试验的药物批准率 (27.2%)显著高于美国 (10.3%)，为全球抗癌药物开发策略提供了重要参考。

2025年7月，美欧宣布达成一项贸易协议，尽管细节仍在磋商中，但该协议被广泛认为严重倾向美国利益。本文围绕该协议的内容与争议、各方主观态度、客观经济影响及其达成原因展开分析。

期刊简介《中国国际战略评论》（CISR）刊登世界政治和国际战略研究领域的原创文章，涵盖中国及其外交关系等领域。本刊鼓励作者提供前沿研究成果和政策分析。期刊作者来自不同国家和地区，旨在成为连接中国战略视角与国际社会战略视角的桥梁。期刊目录1China– ...